The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Iopamidol Injection Market Research Report 2025
Synopsis
The global Iopamidol Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Iopamidol Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Iopamidol Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Iopamidol Injection include Bracco Imaging, Sanochemia, Consentis, T2Pharma, Bayer, Takeda, Fuji Pharma, Hikari Pharmaceutical and BeiLu Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Iopamidol Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iopamidol Injection.
Report Scope
The Iopamidol Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iopamidol Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iopamidol Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bracco Imaging
Sanochemia
Consentis
T2Pharma
Bayer
Takeda
Fuji Pharma
Hikari Pharmaceutical
BeiLu Pharma
Segment by Type
9 g I/ 30 mL
11.1 g I/ 30 mL
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iopamidol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Iopamidol Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Iopamidol Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Iopamidol Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Iopamidol Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Iopamidol Injection include Bracco Imaging, Sanochemia, Consentis, T2Pharma, Bayer, Takeda, Fuji Pharma, Hikari Pharmaceutical and BeiLu Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Iopamidol Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iopamidol Injection.
Report Scope
The Iopamidol Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iopamidol Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iopamidol Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bracco Imaging
Sanochemia
Consentis
T2Pharma
Bayer
Takeda
Fuji Pharma
Hikari Pharmaceutical
BeiLu Pharma
Segment by Type
9 g I/ 30 mL
11.1 g I/ 30 mL
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iopamidol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Iopamidol Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Iopamidol Injection Market Overview
1.1 Product Overview and Scope of Iopamidol Injection
1.2 Iopamidol Injection Segment by Type
1.2.1 Global Iopamidol Injection Market Value Comparison by Type (2024-2030)
1.2.2 9 g I/ 30 mL
1.2.3 11.1 g I/ 30 mL
1.2.4 Others
1.3 Iopamidol Injection Segment by Application
1.3.1 Global Iopamidol Injection Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Iopamidol Injection Market Size Estimates and Forecasts
1.4.1 Global Iopamidol Injection Revenue 2019-2030
1.4.2 Global Iopamidol Injection Sales 2019-2030
1.4.3 Global Iopamidol Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Iopamidol Injection Market Competition by Manufacturers
2.1 Global Iopamidol Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Iopamidol Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Iopamidol Injection Average Price by Manufacturers (2019-2024)
2.4 Global Iopamidol Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Iopamidol Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Iopamidol Injection, Product Type & Application
2.7 Iopamidol Injection Market Competitive Situation and Trends
2.7.1 Iopamidol Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Iopamidol Injection Players Market Share by Revenue
2.7.3 Global Iopamidol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Iopamidol Injection Retrospective Market Scenario by Region
3.1 Global Iopamidol Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Iopamidol Injection Global Iopamidol Injection Sales by Region: 2019-2030
3.2.1 Global Iopamidol Injection Sales by Region: 2019-2024
3.2.2 Global Iopamidol Injection Sales by Region: 2025-2030
3.3 Global Iopamidol Injection Global Iopamidol Injection Revenue by Region: 2019-2030
3.3.1 Global Iopamidol Injection Revenue by Region: 2019-2024
3.3.2 Global Iopamidol Injection Revenue by Region: 2025-2030
3.4 North America Iopamidol Injection Market Facts & Figures by Country
3.4.1 North America Iopamidol Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Iopamidol Injection Sales by Country (2019-2030)
3.4.3 North America Iopamidol Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Iopamidol Injection Market Facts & Figures by Country
3.5.1 Europe Iopamidol Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Iopamidol Injection Sales by Country (2019-2030)
3.5.3 Europe Iopamidol Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Iopamidol Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Iopamidol Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Iopamidol Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Iopamidol Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Iopamidol Injection Market Facts & Figures by Country
3.7.1 Latin America Iopamidol Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Iopamidol Injection Sales by Country (2019-2030)
3.7.3 Latin America Iopamidol Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Iopamidol Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Iopamidol Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Iopamidol Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Iopamidol Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Iopamidol Injection Sales by Type (2019-2030)
4.1.1 Global Iopamidol Injection Sales by Type (2019-2024)
4.1.2 Global Iopamidol Injection Sales by Type (2025-2030)
4.1.3 Global Iopamidol Injection Sales Market Share by Type (2019-2030)
4.2 Global Iopamidol Injection Revenue by Type (2019-2030)
4.2.1 Global Iopamidol Injection Revenue by Type (2019-2024)
4.2.2 Global Iopamidol Injection Revenue by Type (2025-2030)
4.2.3 Global Iopamidol Injection Revenue Market Share by Type (2019-2030)
4.3 Global Iopamidol Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Iopamidol Injection Sales by Application (2019-2030)
5.1.1 Global Iopamidol Injection Sales by Application (2019-2024)
5.1.2 Global Iopamidol Injection Sales by Application (2025-2030)
5.1.3 Global Iopamidol Injection Sales Market Share by Application (2019-2030)
5.2 Global Iopamidol Injection Revenue by Application (2019-2030)
5.2.1 Global Iopamidol Injection Revenue by Application (2019-2024)
5.2.2 Global Iopamidol Injection Revenue by Application (2025-2030)
5.2.3 Global Iopamidol Injection Revenue Market Share by Application (2019-2030)
5.3 Global Iopamidol Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporation Information
6.1.2 Bracco Imaging Description and Business Overview
6.1.3 Bracco Imaging Iopamidol Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bracco Imaging Iopamidol Injection Product Portfolio
6.1.5 Bracco Imaging Recent Developments/Updates
6.2 Sanochemia
6.2.1 Sanochemia Corporation Information
6.2.2 Sanochemia Description and Business Overview
6.2.3 Sanochemia Iopamidol Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanochemia Iopamidol Injection Product Portfolio
6.2.5 Sanochemia Recent Developments/Updates
6.3 Consentis
6.3.1 Consentis Corporation Information
6.3.2 Consentis Description and Business Overview
6.3.3 Consentis Iopamidol Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Consentis Iopamidol Injection Product Portfolio
6.3.5 Consentis Recent Developments/Updates
6.4 T2Pharma
6.4.1 T2Pharma Corporation Information
6.4.2 T2Pharma Description and Business Overview
6.4.3 T2Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 T2Pharma Iopamidol Injection Product Portfolio
6.4.5 T2Pharma Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Iopamidol Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Iopamidol Injection Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Takeda
6.6.1 Takeda Corporation Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Iopamidol Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Takeda Iopamidol Injection Product Portfolio
6.6.5 Takeda Recent Developments/Updates
6.7 Fuji Pharma
6.6.1 Fuji Pharma Corporation Information
6.6.2 Fuji Pharma Description and Business Overview
6.6.3 Fuji Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fuji Pharma Iopamidol Injection Product Portfolio
6.7.5 Fuji Pharma Recent Developments/Updates
6.8 Hikari Pharmaceutical
6.8.1 Hikari Pharmaceutical Corporation Information
6.8.2 Hikari Pharmaceutical Description and Business Overview
6.8.3 Hikari Pharmaceutical Iopamidol Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hikari Pharmaceutical Iopamidol Injection Product Portfolio
6.8.5 Hikari Pharmaceutical Recent Developments/Updates
6.9 BeiLu Pharma
6.9.1 BeiLu Pharma Corporation Information
6.9.2 BeiLu Pharma Description and Business Overview
6.9.3 BeiLu Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BeiLu Pharma Iopamidol Injection Product Portfolio
6.9.5 BeiLu Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Iopamidol Injection Industry Chain Analysis
7.2 Iopamidol Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Iopamidol Injection Production Mode & Process
7.4 Iopamidol Injection Sales and Marketing
7.4.1 Iopamidol Injection Sales Channels
7.4.2 Iopamidol Injection Distributors
7.5 Iopamidol Injection Customers
8 Iopamidol Injection Market Dynamics
8.1 Iopamidol Injection Industry Trends
8.2 Iopamidol Injection Market Drivers
8.3 Iopamidol Injection Market Challenges
8.4 Iopamidol Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Iopamidol Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Iopamidol Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Iopamidol Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Iopamidol Injection Sales (K L) of Key Manufacturers (2019-2024)
Table 5. Global Iopamidol Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Iopamidol Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Iopamidol Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Iopamidol Injection Average Price (US$/L) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Iopamidol Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Iopamidol Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Iopamidol Injection, Product Type & Application
Table 12. Global Key Manufacturers of Iopamidol Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Iopamidol Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iopamidol Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Iopamidol Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Iopamidol Injection Sales by Region (2019-2024) & (K L)
Table 18. Global Iopamidol Injection Sales Market Share by Region (2019-2024)
Table 19. Global Iopamidol Injection Sales by Region (2025-2030) & (K L)
Table 20. Global Iopamidol Injection Sales Market Share by Region (2025-2030)
Table 21. Global Iopamidol Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Iopamidol Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Iopamidol Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Iopamidol Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Iopamidol Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Iopamidol Injection Sales by Country (2019-2024) & (K L)
Table 27. North America Iopamidol Injection Sales by Country (2025-2030) & (K L)
Table 28. North America Iopamidol Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Iopamidol Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Iopamidol Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Iopamidol Injection Sales by Country (2019-2024) & (K L)
Table 32. Europe Iopamidol Injection Sales by Country (2025-2030) & (K L)
Table 33. Europe Iopamidol Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Iopamidol Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Iopamidol Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Iopamidol Injection Sales by Region (2019-2024) & (K L)
Table 37. Asia Pacific Iopamidol Injection Sales by Region (2025-2030) & (K L)
Table 38. Asia Pacific Iopamidol Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Iopamidol Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Iopamidol Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Iopamidol Injection Sales by Country (2019-2024) & (K L)
Table 42. Latin America Iopamidol Injection Sales by Country (2025-2030) & (K L)
Table 43. Latin America Iopamidol Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Iopamidol Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Iopamidol Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Iopamidol Injection Sales by Country (2019-2024) & (K L)
Table 47. Middle East & Africa Iopamidol Injection Sales by Country (2025-2030) & (K L)
Table 48. Middle East & Africa Iopamidol Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Iopamidol Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Iopamidol Injection Sales (K L) by Type (2019-2024)
Table 51. Global Iopamidol Injection Sales (K L) by Type (2025-2030)
Table 52. Global Iopamidol Injection Sales Market Share by Type (2019-2024)
Table 53. Global Iopamidol Injection Sales Market Share by Type (2025-2030)
Table 54. Global Iopamidol Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Iopamidol Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Iopamidol Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Iopamidol Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Iopamidol Injection Price (US$/L) by Type (2019-2024)
Table 59. Global Iopamidol Injection Price (US$/L) by Type (2025-2030)
Table 60. Global Iopamidol Injection Sales (K L) by Application (2019-2024)
Table 61. Global Iopamidol Injection Sales (K L) by Application (2025-2030)
Table 62. Global Iopamidol Injection Sales Market Share by Application (2019-2024)
Table 63. Global Iopamidol Injection Sales Market Share by Application (2025-2030)
Table 64. Global Iopamidol Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Iopamidol Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Iopamidol Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Iopamidol Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Iopamidol Injection Price (US$/L) by Application (2019-2024)
Table 69. Global Iopamidol Injection Price (US$/L) by Application (2025-2030)
Table 70. Bracco Imaging Corporation Information
Table 71. Bracco Imaging Description and Business Overview
Table 72. Bracco Imaging Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 73. Bracco Imaging Iopamidol Injection Product
Table 74. Bracco Imaging Recent Developments/Updates
Table 75. Sanochemia Corporation Information
Table 76. Sanochemia Description and Business Overview
Table 77. Sanochemia Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 78. Sanochemia Iopamidol Injection Product
Table 79. Sanochemia Recent Developments/Updates
Table 80. Consentis Corporation Information
Table 81. Consentis Description and Business Overview
Table 82. Consentis Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 83. Consentis Iopamidol Injection Product
Table 84. Consentis Recent Developments/Updates
Table 85. T2Pharma Corporation Information
Table 86. T2Pharma Description and Business Overview
Table 87. T2Pharma Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 88. T2Pharma Iopamidol Injection Product
Table 89. T2Pharma Recent Developments/Updates
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 93. Bayer Iopamidol Injection Product
Table 94. Bayer Recent Developments/Updates
Table 95. Takeda Corporation Information
Table 96. Takeda Description and Business Overview
Table 97. Takeda Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 98. Takeda Iopamidol Injection Product
Table 99. Takeda Recent Developments/Updates
Table 100. Fuji Pharma Corporation Information
Table 101. Fuji Pharma Description and Business Overview
Table 102. Fuji Pharma Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 103. Fuji Pharma Iopamidol Injection Product
Table 104. Fuji Pharma Recent Developments/Updates
Table 105. Hikari Pharmaceutical Corporation Information
Table 106. Hikari Pharmaceutical Description and Business Overview
Table 107. Hikari Pharmaceutical Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 108. Hikari Pharmaceutical Iopamidol Injection Product
Table 109. Hikari Pharmaceutical Recent Developments/Updates
Table 110. BeiLu Pharma Corporation Information
Table 111. BeiLu Pharma Description and Business Overview
Table 112. BeiLu Pharma Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 113. BeiLu Pharma Iopamidol Injection Product
Table 114. BeiLu Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Iopamidol Injection Distributors List
Table 118. Iopamidol Injection Customers List
Table 119. Iopamidol Injection Market Trends
Table 120. Iopamidol Injection Market Drivers
Table 121. Iopamidol Injection Market Challenges
Table 122. Iopamidol Injection Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Iopamidol Injection
Figure 2. Global Iopamidol Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Iopamidol Injection Market Share by Type in 2023 & 2030
Figure 4. 9 g I/ 30 mL Product Picture
Figure 5. 11.1 g I/ 30 mL Product Picture
Figure 6. Others Product Picture
Figure 7. Global Iopamidol Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Iopamidol Injection Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Global Iopamidol Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Iopamidol Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Iopamidol Injection Sales (2019-2030) & (K L)
Figure 14. Global Iopamidol Injection Average Price (US$/L) & (2019-2030)
Figure 15. Iopamidol Injection Report Years Considered
Figure 16. Iopamidol Injection Sales Share by Manufacturers in 2023
Figure 17. Global Iopamidol Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Iopamidol Injection Players: Market Share by Revenue in 2023
Figure 19. Iopamidol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Iopamidol Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Iopamidol Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Iopamidol Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Iopamidol Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Iopamidol Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Iopamidol Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Iopamidol Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Iopamidol Injection Sales Market Share by Country (2019-2030)
Figure 44. Latin America Iopamidol Injection Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Iopamidol Injection Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Iopamidol Injection Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Iopamidol Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Iopamidol Injection by Type (2019-2030)
Figure 54. Global Revenue Market Share of Iopamidol Injection by Type (2019-2030)
Figure 55. Global Iopamidol Injection Price (US$/L) by Type (2019-2030)
Figure 56. Global Sales Market Share of Iopamidol Injection by Application (2019-2030)
Figure 57. Global Revenue Market Share of Iopamidol Injection by Application (2019-2030)
Figure 58. Global Iopamidol Injection Price (US$/L) by Application (2019-2030)
Figure 59. Iopamidol Injection Value Chain
Figure 60. Iopamidol Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
